Nomura Asset Management CO LTD Zai Lab LTD Transaction History

Nomura Asset Management CO LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$25.3 - $39.67 $221,881 - $347,905	-8,770 Reduced 72.06%	3,400 $94,000
Q1 2023 May 11, 2023	BUY	$30.21 - $48.1 $102,714 - $163,540	3,400 Added 38.77%	12,170 $404,000
Q3 2022 Nov 10, 2022	BUY	$34.2 - $51.69 $57,456 - $86,839	1,680 Added 23.7%	8,770 $300,000
Q1 2022 May 13, 2022	BUY	$27.77 - $64.4 $46,375 - $107,548	1,670 Added 30.81%	7,090 $312,000
Q2 2021 Aug 06, 2021	BUY	$125.11 - $180.0 $70,061 - $100,800	560 Added 11.52%	5,420 $959,000
Q4 2020 Feb 12, 2021	BUY	$81.94 - $135.34 $122,090 - $201,656	1,490 Added 44.21%	4,860 $658,000
Q2 2020 Aug 13, 2020	BUY	$48.82 - $82.53 $164,523 - $278,126	3,370 New	3,370 $277,000

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.